The Biden administration has announced a new proposal to include weight-loss drugs under Medicare and Medicaid programmes. While the plan will help more than seven million Americans struggling with ...
Mounjaro is a treatment for Type 2 diabetes that activates GIP and GLP-1 pathways to help regulate blood sugar. It’s part of ...
Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share ...
Health Canada has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial ...
3h
The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were higher across the board ...
France said Wednesday that it 'intends to continue to work in close collaboration' with Israeli Prime Minister Benjamin Netanyahu despite an arrest warrant issued for him by the world’s top war crimes ...
Canada's warmest winter on record is unlikely to make a repeat performance this year, The Weather Network's chief ...
Pharmaceutical stocks make great additions to any portfolio in any market environment. A good one promises steady revenue ...
Clinicians are advised to screen patients for conditions that would have rendered them ineligible to participate in the ...
The Biden administration plans to require Medicare and Medicaid to offer coverage of weight loss medications for people seeking obesity treatment.The new rule, which was proposed by the administration ...
About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback